Many people receiving buprenorphine to treat opioid addiction fill prescriptions for other opioids during or after treatment, according to a study by Johns Hopkins Bloomberg School of Public Health, reported last week in the journal Addiction. The study looked at pharmacy claims for more than 38,000 new buprenorphine users who filled prescriptions between 2006 and 2013 in 11 states. It found that 43% of patients who received buprenorphine filled an opioid prescription during treatment, and 67% filled an opioid prescription during the 12 months after buprenorphine treatment. “The substantial overlap between buprenorphine and non-buprenorphine opioid use underscores the importance of coordinated efforts to manage opioid use disorder while addressing chronic pain,” the authors said. For more information, see the news release.

Related News Articles

Headline
The Department of Health and Human Services this week awarded $487 million in fiscal year 2019 grants to help states and territories increase access to…
Headline
The three medications approved by the Food and Drug Administration to treat opioid use disorder — methadone, buprenorphine and extended-release naltrexone —…
Headline
In a study of Blue Cross and Blue Shield enrollees reported last week in the New England Journal of Medicine, initial opioid prescriptions declined 54 percent…
Headline
The House Energy and Commerce Health Subcommittee today held a hearing on the president’s fiscal year 2020 budget request for the Department of Health and…
Headline
Eligible organizations can apply through May 6 for up to $1 million each for a three-year period to expand opioid and other substance use disorder services in…
Insights and Analysis
Birmingham VA Medical Center’s weekly, 90-minute shared medical appointments help veterans address opioid reliance.